Are Breast Cancer Molecular Classes Predictive of Survival in Patients with Long Follow-Up?

Figure 1

Kaplan-Meier survival curves with respect to molecular classes in (a) the cohort of BC patients (𝑁=304, 128 BC specific deaths), (b) lymph node negative tumors (𝑁=150, 39 BC specific deaths), and (c) classes in lymph node positive tumors (𝑁=154, 89 BC specific deaths).

(a)

(b)

(c)